FOMO Investing

Brian and Mik
  • 5.0 (4)
  • INVESTING

Brian and Mik explore the world of investing through real-world examples and behavioral economics principles.

  1. Jeremy Raper goes for extra credit at the Humm Group

    JAN 22

    Jeremy Raper goes for extra credit at the Humm Group

    Brian and Mik unpack a live activist situation at Humm Group, a small Australian non-bank lender now facing public pressure from investor Jeremy Raper, who owns ~6% of the company and is pushing for a vote on board change ahead of a February shareholder meeting. They walk through the competing narratives: a founder-led board defending its strategy versus an activist arguing the company is undervalued due to poor governance and capital allocation. Along the way, they discuss downside protection, third-party bids, and special situations. Rather than a stock pitch, this is a case study in pattern recognition: how governance disputes, excess cash, and strategic activist pressure can create asymmetric outcomes.

    39 min
  2. 🥂 2 More FOMO — Holiday Special 2025

    JAN 13

    🥂 2 More FOMO — Holiday Special 2025

    In this year-end episode, Brian and Mik reflect on FOMO Investing—its origins, how the podcast has evolved, and where they hope to take it in 2026. They revisit key themes from the past year, including quantum computing and GLP-1 biotechs, and share plans for the year ahead.

    21 min
  3. R2 - Rivian Reset?

    12/26/2025

    R2 - Rivian Reset?

    After the post-IPO drawdown,  we review whether Rivian is worth another look. Rivian's software-first design, the Volkswagen JV, the R2, as well as its own autonomous driver investments, seem to indicate it may be more than just another EV manufacturer.

    17 min
  4. Sweetgreen (SG), Mixed Greens

    12/15/2025

    Sweetgreen (SG), Mixed Greens

    $15 salads, a 90% drawdown, and a very confused stock market. We explore Sweetgreen as a potential turnaround—what’s broken, what might work, and why demand alone doesn’t save a business. Sometimes the hardest investments aren’t the complex ones—they’re the obvious ones.

    13 min

  5. 12/12/2025

    IonQ Update, November 2025

    In this episode of FOMO Investing, Brian and Mik revisit IonQ (IONQ). Building on our original Theory of the Case from November 2024 and our January 2025 update, we unpack recent developments, including: Management changes (CEO and CFO),IonQ's competitive position in the broader quantum market.Challenging valuation metrics ($15 -16 billion on $100 million of revenue)IonQ's $2 billion in Equity financing at $93/share  (h/t to Andrew Walker's piece that has a great breakdown of this, link below)🔗 Links Theory of the Case — IonQ (Nov 2024): https://fomo.transistor.fm/episodes/theory-of-the-case-ionqIonQ Update (Jan 2025): https://fomo.transistor.fm/episodes/ionq-january-2025Andrew Walker on IonQ financing: https://www.yetanothervalueblog.com/p/the-evolution-of-meme-stock-financingChris Monroe on quantum computing and IonQ https://www.youtube.com/watch?v=-eo_VV0Z4aE&t=6249s

    16 min
  6. Dealable — Oct 31: Trillion-Dollar AI, Billion-Dollar Biotech

    12/10/2025

    Dealable — Oct 31: Trillion-Dollar AI, Billion-Dollar Biotech

    OpenAI is racing toward a trillion-dollar valuation while burning tens of billions on chips, data centers, and Azure commitments. We break down the new capital structure, Microsoft’s leverage, why Zuck is FOMO-building compute, and whether OpenAI should even want to be a public company. Also: the underrated bottlenecks—power, foundries, CUDA, China—and why this boom feels like 1999 with actual revenue. Then we jump to biotech to cover the Pfizer and Novo bidding war for Metsera (Pfizer ultimately won with its $8 billion deal).  The bidding for Metesera  drew at least six bidders and may set-off a chain reaction in the GLP-1 space. We speculate on what this deal might mean for Viking (VKTX) and others in the GLP-1 / obesity space.

    36 min
  7. AI Eats Everything

    12/08/2025

    AI Eats Everything

    The AI & investing episode. Brian and Mik talk about whether AI will actually replace white-collar jobs or just transform them, how professionals can stay relevant by becoming AI-powered specialists, and where value might accrue across chips, power, “boring” traditional industries, and healthcare and drug discovery. They also explore whether giants like OpenAI will hoover up SaaS, how constraints in compute and electricity could shape the next decade, and why the biggest AI winners may come from unknown unknowns we can’t yet see.

    44 min

  8. 10/03/2025

    Dealable, 15th August 2025

    In this episode, Brian and Mik launch a new segment called “Dealable”—where they set aside strict analysis and let their imaginations run on mergers, acquisitions, partnerships, and spin-outs that should happen (even if they probably won’t). The conversation kicks off with Apple’s AI dilemma—is Siri too far behind, and could Apple’s cash hoard finally push them into a big acquisition? Would buying Perplexity or Anthropic give them the AI-native layer their ecosystem needs? And what about the $20B Google search deal that DOJ scrutiny could upend? From there, they turn to Alphabet/Google, exploring what a DOJ-mandated divestiture could look like. Could Waymo be spun out to unlock value? What happens if Chrome were ever separated from Google Search? And whether DOJ case may require a meaningful remedy from Google (and possibly Apple). It’s an episode full of hot takes, half-baked speculation, and a few insights that might just age into real deals. Disclaimer: The views expressed are for entertainment purposes only. This is not investment advice. Please do your own research before making any financial decisions.

    33 min
See All (24)

Ratings & Reviews

5
out of 5
4 Ratings

About

Brian and Mik explore the world of investing through real-world examples and behavioral economics principles.

Information

  • Creator
    Brian and Mik
  • Years Active
    2024 - 2026
  • Episodes
    24
  • Rating
    Clean
  • Copyright
    © 2026 Brian and Mik